Spectral Platforms
Spectral Platforms, based in Monrovia, CA, provides rapid diagnostic tools for infectious diseases, delivering results in minutes.
Founded
2011Spectral Platforms, based in Monrovia, CA, provides rapid diagnostic tools for infectious diseases, delivering results in minutes.
Founded in 2011 and headquartered in Monrovia, California, Spectral Platforms is dedicated to revolutionizing the rapid diagnosis of infectious diseases. The company's mission is to significantly reduce the time required to detect pathogens and determine antimicrobial susceptibility, thereby improving patient outcomes and combating antibiotic resistance. Spectral Platforms offers innovative diagnostic tools such as InSpector, which detects pathogenic microorganisms, and BloodFAST, which characterizes pathogens and their antimicrobial susceptibility directly from blood samples without the need for culture steps.
Spectral Platforms has attracted notable investors and industry experts who support its groundbreaking technology. The company's achievements include developing diagnostic tools that can identify pathogens in just 5 minutes and determine antimicrobial resistance in 40 minutes, compared to traditional methods that take much longer. These advancements have the potential to transform clinical diagnostics, offering faster and more accurate treatment decisions, ultimately impacting public health positively by reducing the spread of infectious diseases and improving antibiotic stewardship.
Companies similar to Spectral Platforms include Specific Diagnostics, PathoGene, NAT Diagnostics and BioAmp diagnostics.
Spectral Platforms was founded in 2011.
Spectral Platforms' headquarters is located in Monrovia, CA, US.
Spectral Platforms' most recent funding round was for $675k (USD) in July 2015.
As of Jul 10, 2015, Spectral Platforms has raised a total of $675k (USD).
Spectral Platforms has 1 employee as of Feb 5, 2024.
